Specific Clinical Experience Investigation for long-term use of Bydureon subcutaneous injection 2 mg and Bydureon SC Pen 2 mg (PMS Bydureon Long Term Use SCEI) First published 18/04/2017 Last updated 14/03/2024 EU PAS number:EUPAS18608 Study Finalised